Furthermore, HULC overexpression in vivo induced tumor formation, and reduced ATG7, LC3 expression, while inducing SQSTM1 expression; however, we found that HULC overexpression did not influence ATG5, ATG12, Beclin-1, VPS34, P150 or UVRAG expression. The gene discussed is MAP1LC3A; the disease is neoplasm.